The Spokesman-Review Local health sciences company Gestalt Diagnostics says it has achieved a significant milestone by using artificial intelligence and digital pathology to improve patient care. BioReference Laboratories, an OPKO Health company that serves more than 19 million patients per year, has adopted Gestalt Diagnostics’ digital pathology platform in combination with an algorithm developed by […]
28
Dec
Dec
The arrival of a new year often sparks inspiration for setting new intentions. As many of us consider making New Year health resolutions, a good starting point may be getting to know more about your health and wellness through an annual visit to your healthcare provider. Due to the COVID-19 pandemic, this approach could be […]
22
Dec
Dec
Each year, the holiday season brings opportunities for festive fun. However, with the emergence of the Omicron variant amid the continuing COVID-19 pandemic, planning for safe holiday activities could still be a challenge. Though reducing your risk of exposure to COVID-19 to zero may be difficult – here, we offer a few creative holiday activities, […]
The Associated Press The NFL is requiring coaches, front-office staff and team personnel to receive a COVID-19 booster by Dec. 27. In a memo sent to teams on Monday and obtained by The Associated Press, the league said: “Given the increased prevalence of the virus in our communities, our experts have recommended that we implement […]
15
Dec
Dec
Festive celebrations are an important part of the winter holiday season. From parties to feasts to opening presents, many cherished holiday traditions have one thing in common – gathering with friends and family. Taking precautions to help keep loved ones safe from COVID-19 should be an important part of your plan this year, especially with […]
13
Dec
Dec
This December, BioReference is proud to be celebrating an exciting milestone – our 40th anniversary. For over four decades, our dedicated team has worked to build a legacy of scientific expertise through innovative and tailored laboratory test solutions. Join us in celebrating our 40th anniversary and learn more about our dynamic evolution. BioReference Celebrates 40 […]
08
Dec
Dec
MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test. This test is approved for use in men age 45 and older who have not had a prior prostate biopsy or are biopsy negative and have an age-specific abnormal total PSA and/or […]
In case you missed it: Richard Schwabacher, Senior Vice President, Digital Health and Chief Digital Officer, was named a Corporate Finalist for the New York CIO of the Year, for the CIO ORBIE Awards 2021. Skip to the 1:50 mark in the Corporate Finalist video to hear Richard discuss digital transformation and use of technology […]
02
Dec
Dec
As you may have seen in the news, a new variant of SARS-CoV-2, B.1.1.529, has been classified by the World Health Organization (WHO).1 Named “Omicron,” this variant of concern was first reported in South Africa on November 24, 2021.1 With the first case of this variant in the United States confirmed on December 1, 2021,2 […]
29
Nov
Nov
ELMWOOD PARK, N.J., November 29, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), announced COVID-19 testing preparedness for the Omicron Variant. BioReference’s PCR diagnostic tests for SARS-CoV-2 COVID-19 are based on recognizing specific RNA target genes that are common to all coronaviruses. To date, the diagnostic targets have not changed with the novel […]
